Category: 2022 Year in Review - Page 2 - Psychedelic Alpha

Read more about the article Bullseye Chart: The Psychedelic Drug Development Pipeline

Bullseye Chart: The Psychedelic Drug Development Pipeline

Post published:February 8, 2023
Post category:2022 Year in Review

Read more about the article Panel: Neuroimaging in Psychedelic Research

Panel: Neuroimaging in Psychedelic Research

Post published:February 7, 2023
Post category:2022 Year in Review

Read more about the article A Perspective from the ‘Reimagining Psychedelic Trials’ Working Group

A Perspective from the ‘Reimagining Psychedelic Trials’ Working Group

Post published:February 2, 2023
Post category:2022 Year in Review

Read more about the article Historical Insights on the Psychedelic Renaissance

Historical Insights on the Psychedelic Renaissance

Post published:February 2, 2023
Post category:2022 Year in Review

Read more about the article A Spotlight on Psychedelic Research Methods

A Spotlight on Psychedelic Research Methods

Post published:February 2, 2023
Post category:2022 Year in Review

Read more about the article Panel: Psychedelic Research Methods

Panel: Psychedelic Research Methods

Post published:February 2, 2023
Post category:2022 Year in Review

Read more about the article The Agenda for Economic Analyses of Psychedelic-assisted Therapy

The Agenda for Economic Analyses of Psychedelic-assisted Therapy

Post published:February 1, 2023
Post category:2022 Year in Review

Read more about the article A Perspective on Providers: Scaling PAT in a Time of Therapist Shortages

A Perspective on Providers: Scaling PAT in a Time of Therapist Shortages

Post published:February 1, 2023
Post category:2022 Year in Review

Read more about the article Making “Access” A Meaningful Part of Every Conversation about Psychedelic Therapy

Making “Access” A Meaningful Part of Every Conversation about Psychedelic Therapy

Post published:February 1, 2023
Post category:2022 Year in Review

Read more about the article Psychedelic Therapies: From Approvals to Access

Psychedelic Therapies: From Approvals to Access

Post published:February 1, 2023
Post category:2022 Year in Review

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.